Microbot Medical (MBOT) Analyst & Key Data

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

3

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.45

Median Target+227.59%

$4.75

Potential upside vs current price

DCF Value-94.98%

$0.07

Potential downside vs current price

Current Stock Price

$1.45

Median Target+227.59%

$4.75

Potential upside vs current price

DCF Value-94.98%

$0.07

Potential downside vs current price

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

3

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.45

Median Target+227.59%

$4.75

Potential upside vs current price

DCF Value-94.98%

$0.07

Potential downside vs current price

Current Stock Price

$1.45

Median Target+227.59%

$4.75

Potential upside vs current price

DCF Value-94.98%

$0.07

Potential downside vs current price

Microbot Medical Inc.